FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to treatment of climacteric syndrome in females with contraindications to hormone replacement therapy (HRT) or its refusal. Dalargin 0.1% solution is injected intramuscularly, 2.0 ml 2 times day for 30 days.
EFFECT: invention provides effective treatment of climacteric syndrome in women.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING CHRONIC KIDNEY DISEASE WITH DALARGIN | 2023 |
|
RU2819638C1 |
| METHOD OF TREATING DIABETES MELLITUS IN COMPLEX WITH DALARGIN | 2023 |
|
RU2816021C1 |
| METHOD OF TREATING ENDOCRINE AUTOIMMUNE OPHTHALMOPATHY | 2024 |
|
RU2819981C1 |
| METHOD OF TREATING CLIMACTERIC SYNDROME IN PREMENOPAUSAL FEMALES | 2014 |
|
RU2564088C1 |
| METHOD OF PREVENTION AND TREATMENT OF CLIMACTERIC SYNDROME IN WOMEN OF PREMENOPAUSAL PERIOD | 2011 |
|
RU2477080C1 |
| METHOD OF TREATING HYPOTHYROIDISM WITH DALARGIN | 2023 |
|
RU2814749C1 |
| METHOD OF TREATING KNEE OSTEOARTHRITIS | 2024 |
|
RU2822321C1 |
| METHOD OF TREATING DEGREE 1 DISCIRCULATORY ENCEPHALOPATHY COMPLICATED BY CLIMACTERIC SYNDROME | 2010 |
|
RU2429856C1 |
| LOCAL AND EXTERNAL SYGETHIN-BASED PHARMACEUTICAL COMPOSITION APPLIED IN MENOPAUSAL DISORDERS | 2007 |
|
RU2360670C1 |
| METHOD FOR TREATING CLIMACTERIC SYNDROME | 2005 |
|
RU2284827C1 |
